136 related articles for article (PubMed ID: 35173861)
1. Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
Xie Q; Wang J; Wu W; Zhao Y
Am J Transl Res; 2022; 14(1):421-431. PubMed ID: 35173861
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line.
Fu L; Yin F; Li XR; Han BK; Zhang C; Wang JW; Wang YQ; Bi YF; Liu HM
Anticancer Drugs; 2018 Jul; 29(6):491-502. PubMed ID: 29683800
[TBL] [Abstract][Full Text] [Related]
3. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
5. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.
Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
Li G; Xu D; Sun J; Zhao S; Zheng D
Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
[TBL] [Abstract][Full Text] [Related]
7. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
[TBL] [Abstract][Full Text] [Related]
8. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
9. Activation of Glycolysis by MCM10 Increases Stemness and Paclitaxel Resistance in Gastric Cancer Cells.
Wu Z; Fang Y; Wu J; Wang J; Ling Y; Liu T; Tong Q; Yao Y
Turk J Gastroenterol; 2023 Nov; 34(11):1107-1115. PubMed ID: 37860833
[TBL] [Abstract][Full Text] [Related]
10. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
[TBL] [Abstract][Full Text] [Related]
11. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
12. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR‑185 promotes apoptosis of the human gastric cancer cell line MGC803.
Fan L; Tan B; Li Y; Zhao Q; Yuan H; Liu Y; Wang D; Zhang Z
Mol Med Rep; 2018 Feb; 17(2):3115-3122. PubMed ID: 29257260
[TBL] [Abstract][Full Text] [Related]
14. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.
Lin Y; Zhai E; Liao B; Xu L; Zhang X; Peng S; He Y; Cai S; Zeng Z; Chen M
Oncotarget; 2017 Feb; 8(7):11990-12002. PubMed ID: 28061477
[TBL] [Abstract][Full Text] [Related]
15. Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2.
Hu Y; Zhou N; Wang R
J BUON; 2021; 26(2):613-619. PubMed ID: 34077013
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
Wu F; Li J; Guo N; Wang XH; Liao YQ
Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
[TBL] [Abstract][Full Text] [Related]
17. Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil.
Xu Z; Hu C; Chen S; Zhang C; Yu J; Wang X; Lv H; Cheng X
Cancer Manag Res; 2019; 11():4905-4915. PubMed ID: 31213909
[No Abstract] [Full Text] [Related]
18. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Wang YX; Cai H; Jiang G; Zhou TB; Wu H
Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells.
Zhang J; Wei Y; Min J; Wang Y; Yin L; Cao G; Shen H
Oncol Lett; 2020 Jan; 19(1):350-358. PubMed ID: 31897147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]